Rank | Gene Set | Z-score |
---|---|---|
1 | protein heterotrimerization (GO:0070208) | 5.05627230 |
2 | extracellular fibril organization (GO:0043206) | 4.77923388 |
3 | complement activation, alternative pathway (GO:0006957) | 4.50809784 |
4 | regulation of protein activation cascade (GO:2000257) | 4.42340647 |
5 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 4.39364010 |
6 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.34344097 |
7 | protein carboxylation (GO:0018214) | 4.34344097 |
8 | L-phenylalanine catabolic process (GO:0006559) | 4.32500421 |
9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.32500421 |
10 | regulation of complement activation (GO:0030449) | 4.31416398 |
11 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.17304401 |
12 | cell migration involved in heart development (GO:0060973) | 4.16991429 |
13 | * collagen fibril organization (GO:0030199) | 4.15425663 |
14 | metanephric mesenchyme development (GO:0072075) | 4.14066712 |
15 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 4.12232128 |
16 | fibril organization (GO:0097435) | 4.10601144 |
17 | L-phenylalanine metabolic process (GO:0006558) | 4.08355172 |
18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.08355172 |
19 | regulation of fibrinolysis (GO:0051917) | 4.06569908 |
20 | homocysteine metabolic process (GO:0050667) | 4.05503133 |
21 | glomerular filtration (GO:0003094) | 3.98439125 |
22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.96574745 |
23 | negative regulation of fibrinolysis (GO:0051918) | 3.95998445 |
24 | alpha-linolenic acid metabolic process (GO:0036109) | 3.91719168 |
25 | positive regulation of fatty acid oxidation (GO:0046321) | 3.85261667 |
26 | aromatic amino acid family catabolic process (GO:0009074) | 3.77205450 |
27 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.75466784 |
28 | glomerular basement membrane development (GO:0032836) | 3.70345083 |
29 | glyoxylate metabolic process (GO:0046487) | 3.68142350 |
30 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.65818006 |
31 | bone trabecula formation (GO:0060346) | 3.63962031 |
32 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.62476033 |
33 | renal filtration (GO:0097205) | 3.61247986 |
34 | kidney mesenchyme development (GO:0072074) | 3.60335152 |
35 | axon extension involved in axon guidance (GO:0048846) | 3.59511892 |
36 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.59511892 |
37 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.58721124 |
38 | regulation of plasminogen activation (GO:0010755) | 3.56904324 |
39 | * collagen metabolic process (GO:0032963) | 3.50901127 |
40 | bile acid biosynthetic process (GO:0006699) | 3.50850479 |
41 | urea metabolic process (GO:0019627) | 3.46910001 |
42 | urea cycle (GO:0000050) | 3.46910001 |
43 | paraxial mesoderm development (GO:0048339) | 3.45769278 |
44 | chondrocyte development (GO:0002063) | 3.44208593 |
45 | dermatan sulfate biosynthetic process (GO:0030208) | 3.43851849 |
46 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.43663357 |
47 | kynurenine metabolic process (GO:0070189) | 3.37828422 |
48 | smooth muscle tissue development (GO:0048745) | 3.37086621 |
49 | * multicellular organismal macromolecule metabolic process (GO:0044259) | 3.36577401 |
50 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.36537319 |
51 | * collagen catabolic process (GO:0030574) | 3.34699405 |
52 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.34241676 |
53 | sulfur amino acid catabolic process (GO:0000098) | 3.34008070 |
54 | negative regulation of protein activation cascade (GO:2000258) | 3.32822133 |
55 | dermatan sulfate metabolic process (GO:0030205) | 3.30468656 |
56 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.30342711 |
57 | opsonization (GO:0008228) | 3.30044538 |
58 | tryptophan catabolic process (GO:0006569) | 3.29651587 |
59 | indole-containing compound catabolic process (GO:0042436) | 3.29651587 |
60 | indolalkylamine catabolic process (GO:0046218) | 3.29651587 |
61 | high-density lipoprotein particle remodeling (GO:0034375) | 3.26037245 |
62 | * multicellular organismal metabolic process (GO:0044236) | 3.25570842 |
63 | lysine metabolic process (GO:0006553) | 3.25289550 |
64 | lysine catabolic process (GO:0006554) | 3.25289550 |
65 | fibrinolysis (GO:0042730) | 3.25152974 |
66 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.24856306 |
67 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.23104964 |
68 | positive regulation of lipid catabolic process (GO:0050996) | 3.19409975 |
69 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.18474553 |
70 | tryptophan metabolic process (GO:0006568) | 3.17755136 |
71 | chondrocyte proliferation (GO:0035988) | 3.15592369 |
72 | * multicellular organismal catabolic process (GO:0044243) | 3.15076030 |
73 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.15001650 |
74 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 3.14482488 |
75 | regulation of triglyceride catabolic process (GO:0010896) | 3.14432781 |
76 | negative regulation of cartilage development (GO:0061037) | 3.14060322 |
77 | extracellular regulation of signal transduction (GO:1900115) | 3.11294708 |
78 | extracellular negative regulation of signal transduction (GO:1900116) | 3.11294708 |
79 | plasma lipoprotein particle clearance (GO:0034381) | 3.10270102 |
80 | nitrogen cycle metabolic process (GO:0071941) | 3.10040644 |
81 | negative regulation of catenin import into nucleus (GO:0035414) | 3.09976366 |
82 | cell proliferation involved in metanephros development (GO:0072203) | 3.08807014 |
83 | reverse cholesterol transport (GO:0043691) | 3.05648602 |
84 | acylglycerol homeostasis (GO:0055090) | 3.02095121 |
85 | triglyceride homeostasis (GO:0070328) | 3.02095121 |
86 | fatty acid transmembrane transport (GO:1902001) | 2.98575241 |
87 | * extracellular matrix organization (GO:0030198) | 2.97819417 |
88 | amino-acid betaine metabolic process (GO:0006577) | 2.97577149 |
89 | * extracellular structure organization (GO:0043062) | 2.96854987 |
90 | extracellular matrix assembly (GO:0085029) | 2.95880954 |
91 | bile acid metabolic process (GO:0008206) | 2.95137853 |
92 | heart morphogenesis (GO:0003007) | 2.94764959 |
93 | negative regulation of complement activation (GO:0045916) | 2.93955605 |
94 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.93899750 |
95 | phospholipid homeostasis (GO:0055091) | 2.92693873 |
96 | hippo signaling (GO:0035329) | 2.92607617 |
97 | * extracellular matrix disassembly (GO:0022617) | 2.92578961 |
98 | basement membrane organization (GO:0071711) | 2.92277432 |
99 | positive regulation of mesenchymal cell proliferation (GO:0002053) | 2.91790018 |
100 | phospholipid efflux (GO:0033700) | 2.91576349 |
101 | negative regulation of fatty acid transport (GO:2000192) | 2.91202839 |
102 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.90260741 |
103 | cysteine metabolic process (GO:0006534) | 2.89386942 |
104 | regulation of fatty acid oxidation (GO:0046320) | 2.88466413 |
105 | tyrosine metabolic process (GO:0006570) | 2.88245503 |
106 | cardiac myofibril assembly (GO:0055003) | 2.87570393 |
107 | complement activation (GO:0006956) | 2.87549984 |
108 | lung vasculature development (GO:0060426) | 2.87509464 |
109 | wound healing, spreading of epidermal cells (GO:0035313) | 2.86803468 |
110 | skin morphogenesis (GO:0043589) | 2.86514626 |
111 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.85187060 |
112 | cellular glucuronidation (GO:0052695) | 2.84471249 |
113 | endodermal cell differentiation (GO:0035987) | 2.83511577 |
114 | endocrine hormone secretion (GO:0060986) | 2.82441036 |
115 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.82395426 |
116 | epoxygenase P450 pathway (GO:0019373) | 2.82059477 |
117 | organ induction (GO:0001759) | 2.81017194 |
118 | protein-lipid complex remodeling (GO:0034368) | 2.80868542 |
119 | macromolecular complex remodeling (GO:0034367) | 2.80868542 |
120 | plasma lipoprotein particle remodeling (GO:0034369) | 2.80868542 |
121 | complement activation, classical pathway (GO:0006958) | 2.79887065 |
122 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.79772549 |
123 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.77368522 |
124 | outer ear morphogenesis (GO:0042473) | 2.77219269 |
125 | negative regulation of embryonic development (GO:0045992) | 2.76875876 |
126 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 2.76007212 |
127 | carnitine shuttle (GO:0006853) | 2.74546425 |
128 | regulation of cholesterol homeostasis (GO:2000188) | 2.74171150 |
129 | positive regulation of glycogen metabolic process (GO:0070875) | 2.73733072 |
130 | serine family amino acid catabolic process (GO:0009071) | 2.71951745 |
131 | digestive tract development (GO:0048565) | 2.71804682 |
132 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.71338038 |
133 | embryonic cranial skeleton morphogenesis (GO:0048701) | 2.70366387 |
134 | midgut development (GO:0007494) | 2.69217568 |
135 | regulation of cholesterol esterification (GO:0010872) | 2.69196896 |
136 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.67982436 |
137 | keratan sulfate catabolic process (GO:0042340) | 2.66531247 |
138 | lipoprotein metabolic process (GO:0042157) | 2.66393492 |
139 | regulation of mesenchymal cell proliferation (GO:0010464) | 2.65322662 |
140 | middle ear morphogenesis (GO:0042474) | 2.63575819 |
141 | endothelial cell morphogenesis (GO:0001886) | 2.63023195 |
142 | fatty acid beta-oxidation (GO:0006635) | 2.62834426 |
143 | aromatic amino acid family metabolic process (GO:0009072) | 2.62776952 |
144 | glial cell migration (GO:0008347) | 2.62435992 |
145 | bile acid and bile salt transport (GO:0015721) | 2.62419580 |
146 | negative regulation of lipase activity (GO:0060192) | 2.62409855 |
147 | negative regulation of sterol transport (GO:0032372) | 2.61830382 |
148 | negative regulation of cholesterol transport (GO:0032375) | 2.61830382 |
149 | positive regulation of smoothened signaling pathway (GO:0045880) | 2.61681141 |
150 | cellular ketone body metabolic process (GO:0046950) | 2.61547064 |
151 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.61206873 |
152 | alpha-amino acid catabolic process (GO:1901606) | 2.60814232 |
153 | protein localization to cell surface (GO:0034394) | 2.58981666 |
154 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.58692627 |
155 | vasculature development (GO:0001944) | 2.58457901 |
156 | regulation of establishment of planar polarity (GO:0090175) | 2.57854415 |
157 | 2-oxoglutarate metabolic process (GO:0006103) | 2.57500068 |
158 | cellular response to amino acid stimulus (GO:0071230) | 2.57258767 |
159 | acetyl-CoA metabolic process (GO:0006084) | 2.56933867 |
160 | negative regulation of blood coagulation (GO:0030195) | 2.56758505 |
161 | negative regulation of hemostasis (GO:1900047) | 2.56758505 |
162 | protein activation cascade (GO:0072376) | 2.56676057 |
163 | artery morphogenesis (GO:0048844) | 2.55928791 |
164 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.55613779 |
165 | cell differentiation involved in metanephros development (GO:0072202) | 2.54889328 |
166 | myelination in peripheral nervous system (GO:0022011) | 2.54461813 |
167 | peripheral nervous system axon ensheathment (GO:0032292) | 2.54461813 |
168 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.53081473 |
169 | craniofacial suture morphogenesis (GO:0097094) | 2.53041843 |
170 | eye morphogenesis (GO:0048592) | 2.52387568 |
171 | regulation of cardioblast differentiation (GO:0051890) | 2.51881299 |
172 | negative regulation of BMP signaling pathway (GO:0030514) | 2.51875149 |
173 | peptide cross-linking (GO:0018149) | 2.50191103 |
174 | non-canonical Wnt signaling pathway (GO:0035567) | 2.48812860 |
175 | regulation of chondrocyte differentiation (GO:0032330) | 2.47967689 |
176 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.47780156 |
177 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 2.47362024 |
178 | convergent extension (GO:0060026) | 2.47348522 |
179 | mesenchyme morphogenesis (GO:0072132) | 2.46937946 |
180 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.46674246 |
181 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.46674246 |
182 | muscle cell migration (GO:0014812) | 2.46010846 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.31947802 |
2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.56192689 |
3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.48568270 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.93763905 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.85871227 |
6 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.76926279 |
7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.07020116 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.99724271 |
9 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.79618935 |
10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.78040132 |
11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.72653414 |
12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.69037367 |
13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.66103863 |
14 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.50772045 |
15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.47318473 |
16 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.98784648 |
17 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.80558880 |
18 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.79167345 |
19 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.78228310 |
20 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.74157338 |
21 | CJUN_26792858_Chip-Seq_BT549_Human | 1.73013006 |
22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68934759 |
23 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.68059663 |
24 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.66788204 |
25 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.66371043 |
26 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.65054164 |
27 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.60881735 |
28 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.59470495 |
29 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.58976336 |
30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.58587687 |
31 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.57802697 |
32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.52617507 |
33 | * GBX2_23144817_ChIP-Seq_PC3_Human | 1.49207038 |
34 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.48299474 |
35 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.44106154 |
36 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.43463229 |
37 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.40277215 |
38 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.39387255 |
39 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38567074 |
40 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38567074 |
41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36322872 |
42 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.30913616 |
43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28515121 |
44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27170488 |
45 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.24354074 |
46 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.24124980 |
47 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.23871416 |
48 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.23871416 |
49 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23337581 |
50 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.23158198 |
51 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.22105129 |
52 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.20825860 |
53 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.19813683 |
54 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.19555398 |
55 | * AR_21572438_ChIP-Seq_LNCaP_Human | 1.19530426 |
56 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.19225277 |
57 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19033888 |
58 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.18376331 |
59 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.12391997 |
60 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.12391997 |
61 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.12391997 |
62 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.11633393 |
63 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.11564901 |
64 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.10594205 |
65 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.09518914 |
66 | * SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.09169156 |
67 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.08544197 |
68 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.07210043 |
69 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06340540 |
70 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.06079927 |
71 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.05747758 |
72 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.05466912 |
73 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05059406 |
74 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.04961477 |
75 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.04349788 |
76 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.01992721 |
77 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.01918390 |
78 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01685721 |
79 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.01194296 |
80 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.00594005 |
81 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00435447 |
82 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00251346 |
83 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.99675363 |
84 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.99155602 |
85 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.98699714 |
86 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.97680641 |
87 | * TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.97505496 |
88 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.97425413 |
89 | * TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.97401052 |
90 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.96874088 |
91 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.95434943 |
92 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95385336 |
93 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.94573175 |
94 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94232397 |
95 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.93761646 |
96 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.93712353 |
97 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.92383878 |
98 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89903930 |
99 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.89525678 |
100 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.89525678 |
101 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.88734427 |
102 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.87981474 |
103 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.87807826 |
104 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.87631710 |
105 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.85822030 |
106 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84881953 |
107 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84819022 |
108 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.83437856 |
109 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.82439087 |
110 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.81788273 |
111 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.80881984 |
112 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.80681443 |
113 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.80150317 |
114 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80103898 |
115 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.79468061 |
116 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.78870162 |
117 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.77176977 |
118 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.75628590 |
119 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.75399548 |
120 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.75012643 |
121 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73863951 |
122 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73217370 |
123 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.73045334 |
124 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72736824 |
125 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.72669674 |
126 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.71698945 |
127 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.71590730 |
128 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.71559921 |
129 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.71460341 |
130 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.70926922 |
131 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.70326834 |
132 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.69894457 |
133 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.69729997 |
134 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.69626596 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008438_abnormal_cutaneous_collagen | 8.07164047 |
2 | * MP0005275_abnormal_skin_tensile | 5.01532134 |
3 | * MP0005503_abnormal_tendon_morphology | 4.12609679 |
4 | MP0002139_abnormal_hepatobiliary_system | 3.73514945 |
5 | MP0003705_abnormal_hypodermis_morpholog | 3.67355752 |
6 | MP0005360_urolithiasis | 3.50904795 |
7 | MP0004272_abnormal_basement_membrane | 3.49044685 |
8 | MP0005085_abnormal_gallbladder_physiolo | 2.88150827 |
9 | MP0005365_abnormal_bile_salt | 2.86101207 |
10 | MP0001958_emphysema | 2.79939501 |
11 | MP0003252_abnormal_bile_duct | 2.74316576 |
12 | MP0010368_abnormal_lymphatic_system | 2.53927667 |
13 | MP0003279_aneurysm | 2.46669120 |
14 | MP0002060_abnormal_skin_morphology | 2.20549027 |
15 | MP0010030_abnormal_orbit_morphology | 2.04777648 |
16 | MP0000751_myopathy | 2.04307661 |
17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.02641141 |
18 | MP0009384_cardiac_valve_regurgitation | 1.88193034 |
19 | MP0006054_spinal_hemorrhage | 1.83428540 |
20 | MP0010329_abnormal_lipoprotein_level | 1.81232101 |
21 | * MP0002108_abnormal_muscle_morphology | 1.72667517 |
22 | MP0003941_abnormal_skin_development | 1.58270624 |
23 | MP0002837_dystrophic_cardiac_calcinosis | 1.52096772 |
24 | MP0001243_abnormal_dermal_layer | 1.36533950 |
25 | MP0002295_abnormal_pulmonary_circulatio | 1.33972067 |
26 | MP0003566_abnormal_cell_adhesion | 1.32800607 |
27 | MP0005257_abnormal_intraocular_pressure | 1.32344368 |
28 | MP0003045_fibrosis | 1.32320826 |
29 | MP0001299_abnormal_eye_distance/ | 1.31973872 |
30 | * MP0005508_abnormal_skeleton_morphology | 1.26124723 |
31 | MP0005083_abnormal_biliary_tract | 1.25927525 |
32 | MP0005332_abnormal_amino_acid | 1.25822983 |
33 | MP0002168_other_aberrant_phenotype | 1.24121226 |
34 | MP0001661_extended_life_span | 1.21530427 |
35 | MP0003806_abnormal_nucleotide_metabolis | 1.21395839 |
36 | MP0002254_reproductive_system_inflammat | 1.20319649 |
37 | MP0002138_abnormal_hepatobiliary_system | 1.17206793 |
38 | MP0000428_abnormal_craniofacial_morphol | 1.12792610 |
39 | MP0000049_abnormal_middle_ear | 1.11589647 |
40 | MP0003195_calcinosis | 1.09779026 |
41 | MP0008004_abnormal_stomach_pH | 1.09716452 |
42 | MP0003191_abnormal_cellular_cholesterol | 1.09064805 |
43 | MP0009840_abnormal_foam_cell | 1.08813771 |
44 | MP0000767_abnormal_smooth_muscle | 1.05839006 |
45 | MP0004858_abnormal_nervous_system | 1.04350848 |
46 | MP0000609_abnormal_liver_physiology | 1.03292287 |
47 | MP0003091_abnormal_cell_migration | 1.03244234 |
48 | MP0001666_abnormal_nutrient_absorption | 1.03062259 |
49 | MP0002896_abnormal_bone_mineralization | 1.02542361 |
50 | MP0005023_abnormal_wound_healing | 1.02193641 |
51 | MP0009053_abnormal_anal_canal | 1.00768914 |
52 | MP0005330_cardiomyopathy | 1.00063907 |
53 | MP0002118_abnormal_lipid_homeostasis | 0.99944986 |
54 | MP0001879_abnormal_lymphatic_vessel | 0.97004487 |
55 | MP0002933_joint_inflammation | 0.96673105 |
56 | MP0002282_abnormal_trachea_morphology | 0.95801428 |
57 | MP0009780_abnormal_chondrocyte_physiolo | 0.95715465 |
58 | MP0001177_atelectasis | 0.95173021 |
59 | MP0004130_abnormal_muscle_cell | 0.94214999 |
60 | MP0000762_abnormal_tongue_morphology | 0.93680795 |
61 | MP0010386_abnormal_urinary_bladder | 0.92206333 |
62 | MP0001849_ear_inflammation | 0.92195605 |
63 | MP0000750_abnormal_muscle_regeneration | 0.90283041 |
64 | MP0005319_abnormal_enzyme/_coenzyme | 0.88325876 |
65 | MP0000432_abnormal_head_morphology | 0.88287287 |
66 | MP0003385_abnormal_body_wall | 0.86871734 |
67 | MP0003115_abnormal_respiratory_system | 0.86226381 |
68 | MP0004019_abnormal_vitamin_homeostasis | 0.85931819 |
69 | MP0005670_abnormal_white_adipose | 0.85684239 |
70 | MP0000579_abnormal_nail_morphology | 0.85649541 |
71 | MP0002249_abnormal_larynx_morphology | 0.85517827 |
72 | MP0001542_abnormal_bone_strength | 0.84284468 |
73 | MP0004134_abnormal_chest_morphology | 0.83978925 |
74 | MP0002166_altered_tumor_susceptibility | 0.82642890 |
75 | MP0003935_abnormal_craniofacial_develop | 0.81872369 |
76 | MP0002116_abnormal_craniofacial_bone | 0.81297653 |
77 | MP0005409_darkened_coat_color | 0.81144446 |
78 | MP0010352_gastrointestinal_tract_polyps | 0.80755924 |
79 | MP0001614_abnormal_blood_vessel | 0.80591052 |
80 | MP0009250_abnormal_appendicular_skeleto | 0.79423750 |
81 | MP0002114_abnormal_axial_skeleton | 0.79191217 |
82 | MP0000013_abnormal_adipose_tissue | 0.79105580 |
83 | MP0005220_abnormal_exocrine_pancreas | 0.78851664 |
84 | MP0004087_abnormal_muscle_fiber | 0.77900882 |
85 | MP0000759_abnormal_skeletal_muscle | 0.77767131 |
86 | MP0005595_abnormal_vascular_smooth | 0.77562405 |
87 | MP0004084_abnormal_cardiac_muscle | 0.77359285 |
88 | MP0000534_abnormal_ureter_morphology | 0.77208855 |
89 | MP0002128_abnormal_blood_circulation | 0.76689260 |
90 | MP0002109_abnormal_limb_morphology | 0.76344717 |
91 | MP0002113_abnormal_skeleton_development | 0.75415926 |
92 | MP0005623_abnormal_meninges_morphology | 0.74987884 |
93 | MP0002233_abnormal_nose_morphology | 0.74108820 |
94 | MP0005171_absent_coat_pigmentation | 0.73275927 |
95 | MP0004883_abnormal_blood_vessel | 0.73246074 |
96 | MP0001175_abnormal_lung_morphology | 0.72474994 |
97 | MP0003300_gastrointestinal_ulcer | 0.71661558 |
98 | MP0003755_abnormal_palate_morphology | 0.70986755 |
99 | MP0008775_abnormal_heart_ventricle | 0.70932276 |
100 | MP0000163_abnormal_cartilage_morphology | 0.69790419 |
101 | MP0006138_congestive_heart_failure | 0.69652802 |
102 | MP0002115_abnormal_skeleton_extremities | 0.69039250 |
103 | MP0000749_muscle_degeneration | 0.67241017 |
104 | MP0000538_abnormal_urinary_bladder | 0.67214420 |
105 | MP0001544_abnormal_cardiovascular_syste | 0.66990468 |
106 | MP0005385_cardiovascular_system_phenoty | 0.66990468 |
107 | MP0005666_abnormal_adipose_tissue | 0.66488333 |
108 | MP0000003_abnormal_adipose_tissue | 0.66399058 |
109 | MP0003868_abnormal_feces_composition | 0.66340841 |
110 | * MP0005390_skeleton_phenotype | 0.65123337 |
111 | MP0003937_abnormal_limbs/digits/tail_de | 0.64247705 |
112 | MP0002006_tumorigenesis | 0.64002910 |
113 | MP0002133_abnormal_respiratory_system | 0.63975302 |
114 | MP0005388_respiratory_system_phenotype | 0.63975302 |
115 | MP0002925_abnormal_cardiovascular_devel | 0.63668327 |
116 | MP0005375_adipose_tissue_phenotype | 0.63337793 |
117 | MP0001270_distended_abdomen | 0.63317466 |
118 | MP0001756_abnormal_urination | 0.63286874 |
119 | MP0010630_abnormal_cardiac_muscle | 0.63140053 |
120 | MP0000733_abnormal_muscle_development | 0.63043396 |
121 | * MP0005369_muscle_phenotype | 0.60091530 |
122 | MP0005164_abnormal_response_to | 0.59882190 |
123 | MP0003724_increased_susceptibility_to | 0.58878961 |
124 | MP0004036_abnormal_muscle_relaxation | 0.58267087 |
125 | MP0002697_abnormal_eye_size | 0.58124121 |
126 | MP0002998_abnormal_bone_remodeling | 0.57884914 |
127 | MP0005620_abnormal_muscle_contractility | 0.57740130 |
128 | MP0009643_abnormal_urine_homeostasis | 0.57594247 |
129 | MP0003950_abnormal_plasma_membrane | 0.56904055 |
130 | MP0000462_abnormal_digestive_system | 0.56312334 |
131 | MP0002932_abnormal_joint_morphology | 0.56266153 |
132 | MP0005248_abnormal_Harderian_gland | 0.56052266 |
133 | MP0003011_delayed_dark_adaptation | 0.55747214 |
134 | MP0003942_abnormal_urinary_system | 0.55108922 |
135 | MP0000266_abnormal_heart_morphology | 0.54480874 |
136 | MP0010771_integument_phenotype | 0.51872885 |
137 | MP0003938_abnormal_ear_development | 0.51011203 |
138 | MP0000566_synostosis | 0.49155155 |
139 | MP0003795_abnormal_bone_structure | 0.47932491 |
140 | MP0002127_abnormal_cardiovascular_syste | 0.47542080 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Protrusio acetabuli (HP:0003179) | 6.42222169 |
2 | Premature rupture of membranes (HP:0001788) | 5.34061328 |
3 | Broad metatarsal (HP:0001783) | 5.10095303 |
4 | Ankle contracture (HP:0006466) | 5.03113512 |
5 | Aortic dissection (HP:0002647) | 4.70715217 |
6 | Type 1 muscle fiber predominance (HP:0003803) | 4.43363356 |
7 | Deep venous thrombosis (HP:0002625) | 4.28353248 |
8 | Atrophic scars (HP:0001075) | 4.27814550 |
9 | Increased connective tissue (HP:0009025) | 4.20338196 |
10 | Follicular hyperkeratosis (HP:0007502) | 4.06863011 |
11 | Soft skin (HP:0000977) | 4.05993792 |
12 | Cerebral aneurysm (HP:0004944) | 3.88119057 |
13 | Fragile skin (HP:0001030) | 3.80451776 |
14 | Mitral valve prolapse (HP:0001634) | 3.80161230 |
15 | Complement deficiency (HP:0004431) | 3.68757852 |
16 | Bladder diverticulum (HP:0000015) | 3.63188460 |
17 | Aortic aneurysm (HP:0004942) | 3.61415062 |
18 | Shallow orbits (HP:0000586) | 3.55416065 |
19 | Peritonitis (HP:0002586) | 3.45485926 |
20 | Slender build (HP:0001533) | 3.43927186 |
21 | Striae distensae (HP:0001065) | 3.37277982 |
22 | Dilatation of the ascending aorta (HP:0005111) | 3.29676995 |
23 | Mitral stenosis (HP:0001718) | 3.23856253 |
24 | Vascular tortuosity (HP:0004948) | 3.20955332 |
25 | Xanthomatosis (HP:0000991) | 3.18956235 |
26 | Intrahepatic cholestasis (HP:0001406) | 3.12716760 |
27 | Spinal rigidity (HP:0003306) | 3.04578546 |
28 | Calcaneovalgus deformity (HP:0001848) | 2.97929524 |
29 | Arterial tortuosity (HP:0005116) | 2.87263139 |
30 | Alopecia of scalp (HP:0002293) | 2.84308089 |
31 | Increased variability in muscle fiber diameter (HP:0003557) | 2.81280233 |
32 | Abnormality of dentin (HP:0010299) | 2.80902952 |
33 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.76720029 |
34 | Prolonged partial thromboplastin time (HP:0003645) | 2.76027843 |
35 | Abnormality of complement system (HP:0005339) | 2.75502594 |
36 | Deformed tarsal bones (HP:0008119) | 2.72461367 |
37 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.69664943 |
38 | Blue sclerae (HP:0000592) | 2.68878056 |
39 | Muscle fiber splitting (HP:0003555) | 2.64810186 |
40 | Wrist flexion contracture (HP:0001239) | 2.64610955 |
41 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.62679575 |
42 | Hyperextensible skin (HP:0000974) | 2.62186896 |
43 | Ectopia lentis (HP:0001083) | 2.62109188 |
44 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.57062646 |
45 | Osteolytic defects of the hand bones (HP:0009699) | 2.57062646 |
46 | Hypoalphalipoproteinemia (HP:0003233) | 2.55030816 |
47 | Hyperlipoproteinemia (HP:0010980) | 2.51567014 |
48 | Abnormality of the common coagulation pathway (HP:0010990) | 2.51087950 |
49 | Aneurysm (HP:0002617) | 2.46676289 |
50 | Overgrowth (HP:0001548) | 2.43498691 |
51 | Cardiovascular calcification (HP:0011915) | 2.38924312 |
52 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.38015700 |
53 | Wormian bones (HP:0002645) | 2.36550335 |
54 | Venous insufficiency (HP:0005293) | 2.36361827 |
55 | Hypobetalipoproteinemia (HP:0003563) | 2.35569625 |
56 | Renovascular hypertension (HP:0100817) | 2.34398476 |
57 | Abnormal delivery (HP:0001787) | 2.30906342 |
58 | Hypolipoproteinemia (HP:0010981) | 2.29862825 |
59 | Genu recurvatum (HP:0002816) | 2.28236092 |
60 | Absent frontal sinuses (HP:0002688) | 2.23531768 |
61 | Abnormality of the calcaneus (HP:0008364) | 2.23505053 |
62 | Round ear (HP:0100830) | 2.23282303 |
63 | Limited hip movement (HP:0008800) | 2.23125234 |
64 | Biconcave vertebral bodies (HP:0004586) | 2.22584082 |
65 | Right ventricular cardiomyopathy (HP:0011663) | 2.20553634 |
66 | Persistence of primary teeth (HP:0006335) | 2.20425149 |
67 | Thin bony cortex (HP:0002753) | 2.19861272 |
68 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.19746364 |
69 | Skin nodule (HP:0200036) | 2.19150553 |
70 | Pulmonary artery stenosis (HP:0004415) | 2.18452209 |
71 | Wide anterior fontanel (HP:0000260) | 2.17055227 |
72 | Increased corneal curvature (HP:0100692) | 2.15054403 |
73 | Keratoconus (HP:0000563) | 2.15054403 |
74 | Venous abnormality (HP:0002624) | 2.14937969 |
75 | Myocardial infarction (HP:0001658) | 2.14189470 |
76 | Mild short stature (HP:0003502) | 2.13649469 |
77 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.13214914 |
78 | Joint hemorrhage (HP:0005261) | 2.13033131 |
79 | Cutaneous finger syndactyly (HP:0010554) | 2.11800514 |
80 | Hypoglycemic coma (HP:0001325) | 2.10264488 |
81 | Breech presentation (HP:0001623) | 2.09986901 |
82 | Osteoarthritis (HP:0002758) | 2.09763473 |
83 | Camptodactyly of toe (HP:0001836) | 2.08991558 |
84 | Disproportionate tall stature (HP:0001519) | 2.08613289 |
85 | Infantile muscular hypotonia (HP:0008947) | 2.06840440 |
86 | Joint laxity (HP:0001388) | 2.06836648 |
87 | Abnormality of the intrinsic pathway (HP:0010989) | 2.06801112 |
88 | Epidermoid cyst (HP:0200040) | 2.06575503 |
89 | Hypoplasia of the iris (HP:0007676) | 2.03278431 |
90 | Inguinal hernia (HP:0000023) | 2.02802333 |
91 | Abnormality of the ischium (HP:0003174) | 2.02103233 |
92 | Systemic lupus erythematosus (HP:0002725) | 2.01906149 |
93 | Lymphangioma (HP:0100764) | 2.01527433 |
94 | Mitral regurgitation (HP:0001653) | 2.00806293 |
95 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.00476975 |
96 | Short 4th metacarpal (HP:0010044) | 2.00476975 |
97 | Abnormality of the 4th metacarpal (HP:0010012) | 2.00198731 |
98 | Cutaneous syndactyly (HP:0012725) | 1.98758826 |
99 | Ulnar claw (HP:0001178) | 1.98606568 |
100 | Flat cornea (HP:0007720) | 1.98086205 |
101 | Hyperammonemia (HP:0001987) | 1.97805224 |
102 | Narrow nasal bridge (HP:0000446) | 1.96506045 |
103 | Bowel diverticulosis (HP:0005222) | 1.96353271 |
104 | Distal arthrogryposis (HP:0005684) | 1.94542697 |
105 | Aortic valve stenosis (HP:0001650) | 1.94448077 |
106 | Ketosis (HP:0001946) | 1.91158170 |
107 | Neoplasm of the heart (HP:0100544) | 1.90467909 |
108 | Neonatal short-limb short stature (HP:0008921) | 1.89471817 |
109 | Coronal craniosynostosis (HP:0004440) | 1.89436958 |
110 | Hepatocellular carcinoma (HP:0001402) | 1.88918453 |
111 | Hip contracture (HP:0003273) | 1.88268648 |
112 | Esophageal varix (HP:0002040) | 1.86934665 |
113 | Vertebral compression fractures (HP:0002953) | 1.86895628 |
114 | Generalized amyotrophy (HP:0003700) | 1.86638306 |
115 | Gastrointestinal infarctions (HP:0005244) | 1.86386255 |
116 | Abnormality of the acetabulum (HP:0003170) | 1.85933255 |
117 | Aortic regurgitation (HP:0001659) | 1.85864670 |
118 | Deviation of the hallux (HP:0010051) | 1.84426581 |
119 | Broad long bones (HP:0005622) | 1.83717486 |
120 | Broad ribs (HP:0000885) | 1.83020049 |
121 | Ulnar bowing (HP:0003031) | 1.82391183 |
122 | Spondylolisthesis (HP:0003302) | 1.80957077 |
123 | Gingival overgrowth (HP:0000212) | 1.79773146 |
124 | Nonimmune hydrops fetalis (HP:0001790) | 1.79403353 |
125 | Turricephaly (HP:0000262) | 1.79239821 |
126 | Abnormality of skull ossification (HP:0002703) | 1.78590021 |
127 | Cervical subluxation (HP:0003308) | 1.77818646 |
128 | Hallux valgus (HP:0001822) | 1.76995566 |
129 | Vitreoretinal degeneration (HP:0000655) | 1.75128443 |
130 | Lipoatrophy (HP:0100578) | 1.74700912 |
131 | Decreased skull ossification (HP:0004331) | 1.74677927 |
132 | Spinal cord lesions (HP:0100561) | 1.74658584 |
133 | Syringomyelia (HP:0003396) | 1.74658584 |
134 | Midline defect of the nose (HP:0004122) | 1.73451456 |
135 | Trismus (HP:0000211) | 1.73427197 |
136 | Elbow flexion contracture (HP:0002987) | 1.73149324 |
137 | Hypoplasia of the maxilla (HP:0000327) | 1.71555230 |
138 | Glomerulonephritis (HP:0000099) | 1.68978366 |
Rank | Gene Set | Z-score |
---|---|---|
1 | SIK1 | 4.24441739 |
2 | LATS1 | 3.23222081 |
3 | ERN1 | 3.18245236 |
4 | TRIB3 | 3.15505763 |
5 | TTN | 2.97027845 |
6 | TGFBR2 | 2.79289936 |
7 | FGFR4 | 2.64153963 |
8 | EPHA3 | 2.57258385 |
9 | EEF2K | 2.50804210 |
10 | PDGFRA | 2.50361100 |
11 | DDR2 | 2.44090719 |
12 | BCKDK | 2.32410644 |
13 | TIE1 | 2.30244902 |
14 | PKN2 | 2.17354136 |
15 | FGFR2 | 2.04183075 |
16 | MYLK | 2.04166843 |
17 | EPHB1 | 2.00453520 |
18 | RIPK1 | 1.96103575 |
19 | CAMK1D | 1.83158731 |
20 | PTK6 | 1.72652236 |
21 | AKT3 | 1.65320107 |
22 | EPHB2 | 1.58366088 |
23 | MST1R | 1.56804828 |
24 | DMPK | 1.55507545 |
25 | INSRR | 1.55209927 |
26 | FRK | 1.49539218 |
27 | KIT | 1.41578868 |
28 | NEK9 | 1.39680653 |
29 | MAP3K6 | 1.39154443 |
30 | CAMK1G | 1.35487230 |
31 | FER | 1.34800704 |
32 | PIK3CA | 1.33873762 |
33 | OBSCN | 1.32478156 |
34 | MET | 1.29026278 |
35 | LATS2 | 1.21709362 |
36 | STK3 | 1.17224522 |
37 | JAK1 | 1.11882453 |
38 | PTK2 | 1.11828284 |
39 | FGFR3 | 1.10197837 |
40 | MAP3K7 | 1.06180957 |
41 | STK38L | 1.06140330 |
42 | PAK2 | 1.02614179 |
43 | PDGFRB | 1.01336822 |
44 | PTK2B | 0.98384898 |
45 | MAP3K10 | 0.98326003 |
46 | KDR | 0.98198264 |
47 | PIK3CG | 0.94398108 |
48 | LMTK2 | 0.93407155 |
49 | RET | 0.92505761 |
50 | CLK1 | 0.92247408 |
51 | ERBB2 | 0.91880089 |
52 | FGFR1 | 0.91584630 |
53 | MARK2 | 0.90457507 |
54 | CDK12 | 0.89878903 |
55 | ERBB4 | 0.89561580 |
56 | STK38 | 0.89539765 |
57 | GSK3A | 0.89132187 |
58 | MTOR | 0.87690441 |
59 | BMX | 0.87427219 |
60 | FLT3 | 0.85633237 |
61 | RPS6KA2 | 0.83327289 |
62 | PRKAA2 | 0.80999361 |
63 | MAPK15 | 0.80172371 |
64 | RPS6KC1 | 0.78080390 |
65 | RPS6KL1 | 0.78080390 |
66 | NUAK1 | 0.77254977 |
67 | TYK2 | 0.76847438 |
68 | MELK | 0.75332616 |
69 | ROCK1 | 0.74525763 |
70 | MAP3K3 | 0.73544775 |
71 | PRKD1 | 0.73031401 |
72 | CDK6 | 0.70617920 |
73 | SGK2 | 0.70437607 |
74 | PRKD2 | 0.70157440 |
75 | PRKCH | 0.70145030 |
76 | STK24 | 0.69941780 |
77 | PDK3 | 0.68571194 |
78 | PDK4 | 0.68571194 |
79 | JAK2 | 0.68381440 |
80 | TGFBR1 | 0.66590707 |
81 | MAPK11 | 0.66255770 |
82 | ICK | 0.64598731 |
83 | DYRK1B | 0.62867920 |
84 | RPS6KA6 | 0.62840059 |
85 | BRD4 | 0.60441163 |
86 | LRRK2 | 0.58683157 |
87 | IRAK1 | 0.58160786 |
88 | CSK | 0.56549780 |
89 | PAK3 | 0.55824667 |
90 | MAPK4 | 0.55440056 |
91 | PAK4 | 0.54027939 |
92 | ADRBK1 | 0.52364978 |
93 | MAP2K1 | 0.51840875 |
94 | ILK | 0.51156505 |
95 | MOS | 0.50483526 |
96 | SGK494 | 0.49773113 |
97 | SGK223 | 0.49773113 |
98 | TYRO3 | 0.49552788 |
99 | IGF1R | 0.47641611 |
100 | CHUK | 0.47228806 |
101 | PDK2 | 0.45801332 |
102 | MAPKAPK3 | 0.45753033 |
103 | DAPK2 | 0.44118107 |
104 | MAPK1 | 0.43553542 |
105 | CDC42BPA | 0.41806297 |
106 | PRKAA1 | 0.40504496 |
107 | ROCK2 | 0.40129977 |
108 | SGK3 | 0.39849115 |
109 | INSR | 0.39113255 |
110 | MAPK12 | 0.37978830 |
111 | NLK | 0.37022531 |
112 | PRPF4B | 0.35534268 |
113 | MAPK3 | 0.35397203 |
114 | CAMK4 | 0.35168177 |
115 | PRKACG | 0.34717242 |
116 | PHKG2 | 0.34194400 |
117 | PHKG1 | 0.34194400 |
118 | NTRK1 | 0.33985628 |
119 | SRC | 0.33972314 |
120 | TRPM7 | 0.33834699 |
121 | PRKG2 | 0.32292680 |
122 | MAP2K4 | 0.31477238 |
123 | MAP3K2 | 0.30319811 |
124 | CSF1R | 0.30169837 |
125 | ABL2 | 0.29903265 |
126 | PRKCE | 0.29274735 |
127 | MAPK7 | 0.29179846 |
128 | PRKG1 | 0.29072236 |
129 | MAP2K3 | 0.28843380 |
130 | STK39 | 0.27859980 |
131 | WNK1 | 0.26926231 |
132 | DAPK3 | 0.25602716 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.60962037 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.16740223 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.85666113 |
4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.85051497 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.78098024 |
6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55454467 |
7 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.52687007 |
8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.46290009 |
9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.31011823 |
10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.20788129 |
11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.18035547 |
12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.11827740 |
13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.02795505 |
14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.99143195 |
15 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.98083462 |
16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.85849366 |
17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.82008426 |
18 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 1.78942021 |
19 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.76119532 |
20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.73539316 |
21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.64162343 |
22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.63554126 |
23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.62030398 |
24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.51028368 |
25 | Peroxisome_Homo sapiens_hsa04146 | 1.50281879 |
26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.49591220 |
27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.48442648 |
28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.47731449 |
29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.41418186 |
30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.41269999 |
31 | Renin secretion_Homo sapiens_hsa04924 | 1.40542019 |
32 | Bile secretion_Homo sapiens_hsa04976 | 1.37289104 |
33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.33757837 |
34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.33263243 |
35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.30212406 |
36 | Focal adhesion_Homo sapiens_hsa04510 | 1.29861540 |
37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.28787243 |
38 | Melanoma_Homo sapiens_hsa05218 | 1.26173644 |
39 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.23410233 |
40 | Amoebiasis_Homo sapiens_hsa05146 | 1.22005129 |
41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.20845711 |
42 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.18756314 |
43 | Lysine degradation_Homo sapiens_hsa00310 | 1.18088782 |
44 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.14544745 |
45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.12654253 |
46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.12130898 |
47 | Prostate cancer_Homo sapiens_hsa05215 | 1.12070348 |
48 | Axon guidance_Homo sapiens_hsa04360 | 1.11820630 |
49 | Tight junction_Homo sapiens_hsa04530 | 1.11530192 |
50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.10594324 |
51 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.09343624 |
52 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.09038736 |
53 | ABC transporters_Homo sapiens_hsa02010 | 1.08212902 |
54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.06567778 |
55 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.03709601 |
56 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.03355925 |
57 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.99914340 |
58 | Gap junction_Homo sapiens_hsa04540 | 0.98817653 |
59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.98455992 |
60 | Melanogenesis_Homo sapiens_hsa04916 | 0.98004385 |
61 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.97814772 |
62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.96048587 |
63 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.94837757 |
64 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.94345560 |
65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93136448 |
66 | Glioma_Homo sapiens_hsa05214 | 0.93067248 |
67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92453306 |
68 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.91996836 |
69 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.91905214 |
70 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.90215963 |
71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.89157780 |
72 | Carbon metabolism_Homo sapiens_hsa01200 | 0.87456532 |
73 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.87212854 |
74 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.86178189 |
75 | Insulin resistance_Homo sapiens_hsa04931 | 0.85855000 |
76 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.85794884 |
77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.84547191 |
78 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.84516318 |
79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82601497 |
80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81036160 |
81 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80710270 |
82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.80519047 |
83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78248040 |
84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.74229611 |
85 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.73657795 |
86 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72632937 |
87 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.70709042 |
88 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70355876 |
89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70107511 |
90 | Prion diseases_Homo sapiens_hsa05020 | 0.68402983 |
91 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68239281 |
92 | Endometrial cancer_Homo sapiens_hsa05213 | 0.68111541 |
93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66162055 |
94 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.65111592 |
95 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.64328701 |
96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64177157 |
97 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63831548 |
98 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.63724507 |
99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.62351805 |
100 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.62339366 |
101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62259292 |
102 | Colorectal cancer_Homo sapiens_hsa05210 | 0.61299897 |
103 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59945759 |
104 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.59900670 |
105 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59798205 |
106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59572651 |
107 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59121625 |
108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59063987 |
109 | Malaria_Homo sapiens_hsa05144 | 0.58720390 |
110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58578420 |
111 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57257053 |
112 | Adherens junction_Homo sapiens_hsa04520 | 0.57138569 |
113 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.56216414 |
114 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.55970887 |
115 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.55786386 |
116 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.54990432 |
117 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53715425 |
118 | Viral myocarditis_Homo sapiens_hsa05416 | 0.51835970 |
119 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.50958926 |
120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49237277 |
121 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.47394307 |
122 | Salivary secretion_Homo sapiens_hsa04970 | 0.45946065 |
123 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45916909 |
124 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.45779030 |
125 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.44679971 |
126 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44662834 |
127 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.44400527 |
128 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43993296 |
129 | Pertussis_Homo sapiens_hsa05133 | 0.43881623 |
130 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43477579 |
131 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42155947 |
132 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.40674722 |
133 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40534112 |
134 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40367976 |
135 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40005198 |
136 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.39881768 |
137 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.39641476 |
138 | Other glycan degradation_Homo sapiens_hsa00511 | 0.39575493 |
139 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39307079 |
140 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.37557663 |
141 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.37101681 |
142 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36008750 |
143 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.34707189 |
144 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.32796739 |
145 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.30384724 |
146 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.28186861 |
147 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.27165310 |
148 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26669120 |
149 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.26665589 |
150 | Bladder cancer_Homo sapiens_hsa05219 | 0.25347282 |
151 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.21800836 |
152 | Platelet activation_Homo sapiens_hsa04611 | 0.21228659 |
153 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.20964836 |
154 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20750650 |
155 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.18776063 |
156 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.17725530 |
157 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.17006849 |
158 | Pathways in cancer_Homo sapiens_hsa05200 | 0.15938323 |